546 related articles for article (PubMed ID: 15784036)
21. Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine.
Thomas NJ; Carcillo JA; Herzer WA; Mi Z; Jackson EK
J Pharmacol Exp Ther; 2001 Jan; 296(1):168-74. PubMed ID: 11123377
[TBL] [Abstract][Full Text] [Related]
22. Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial.
Cavallin M; Kamath PS; Merli M; Fasolato S; Toniutto P; Salerno F; Bernardi M; Romanelli RG; Colletta C; Salinas F; Di Giacomo A; Ridola L; Fornasiere E; Caraceni P; Morando F; Piano S; Gatta A; Angeli P;
Hepatology; 2015 Aug; 62(2):567-74. PubMed ID: 25644760
[TBL] [Abstract][Full Text] [Related]
23. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
24. Beneficial haemodynamic and renal sodium handling effects of combined midodrine and octreotide treatment in a cirrhotic patient with large hepatic hydrothorax and mild ascites.
Kalambokis G; Fotopoulos A; Economou M; Tsianos EV
Nephrol Dial Transplant; 2005 Nov; 20(11):2583. PubMed ID: 16105868
[No Abstract] [Full Text] [Related]
25. Low-dose vasopressin increases glomerular filtration rate, but impairs renal oxygenation in post-cardiac surgery patients.
Bragadottir G; Redfors B; Nygren A; Sellgren J; Ricksten SE
Acta Anaesthesiol Scand; 2009 Sep; 53(8):1052-9. PubMed ID: 19572935
[TBL] [Abstract][Full Text] [Related]
26. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
[TBL] [Abstract][Full Text] [Related]
27. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.
Saló J; Guevara M; Fernández-Esparrach G; Bataller R; Ginès A; Jimenez W; Ginès P; Rivera F; Arroyo V; Rodés J
Hepatology; 1997 Jun; 25(6):1338-42. PubMed ID: 9185749
[TBL] [Abstract][Full Text] [Related]
28. [Hepatorenal syndrome: a new therapeutic approach?].
Gerbes AL; Gülberg V
Z Gastroenterol; 1999 Sep; 37(9):983-5. PubMed ID: 10522370
[No Abstract] [Full Text] [Related]
29. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
[TBL] [Abstract][Full Text] [Related]
30. Renal hemodynamics and the renin-angiotensin system in cirrhosis.
Aliaga L; Zozaya JM; Quiroga J; Richter JA; Prieto J
Rev Esp Fisiol; 1989; 45 Suppl():371-5. PubMed ID: 2701770
[TBL] [Abstract][Full Text] [Related]
31. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
32. Effects of long-term administration of octreotide in portal vein-stenosed rats.
Lin HC; Yang MC; Hou MC; Li SM; Huang YT; Yu PC; Tsai YT; Lee SD
Hepatology; 1996 Mar; 23(3):537-43. PubMed ID: 8617434
[TBL] [Abstract][Full Text] [Related]
33. Effects of tezosentan, a dual endothelin receptor antagonist, on the cardiovascular and renal systems of neonatal piglets.
Chin A; Radhakrishnan J; Fornell L; John E
J Pediatr Surg; 2001 Dec; 36(12):1824-8. PubMed ID: 11733915
[TBL] [Abstract][Full Text] [Related]
34. Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites.
Thiesson HC; Skøtt O; Jespersen B; Schaffalitzky de Muckadell OB
Am J Gastroenterol; 2003 Jan; 98(1):180-6. PubMed ID: 12526955
[TBL] [Abstract][Full Text] [Related]
35. Dopamine-induced changes in renal blood flow in normals and in patients with renal dysfunction.
Drieghe B; Manoharan G; Heyndrickx GR; Madaric J; Bartunek J; Sarno G; Vanderheyden M; De Bruyne B
Catheter Cardiovasc Interv; 2008 Nov; 72(5):725-30. PubMed ID: 18949800
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the effect of midodrine versus octreotide on hemodynamic status in cirrhotic patients with ascites.
Minakari M; Faiiaz L; Rowshandel M; Shavakhi A
J Res Med Sci; 2011 Jan; 16(1):87-93. PubMed ID: 21448389
[TBL] [Abstract][Full Text] [Related]
37. Terlipressin in hepatorenal syndrome: Evidence for present indications.
Rajekar H; Chawla Y
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():109-14. PubMed ID: 21199521
[TBL] [Abstract][Full Text] [Related]
38. Effects of octreotide on central hemodynamics and systemic oxygen use in patients with viral cirrhosis.
Lin HC; Hou MC; Lee WC; Huang YT; Lee FY; Chang FY; Tsai YT; Lee SD
Am J Gastroenterol; 1999 Apr; 94(4):1012-7. PubMed ID: 10201475
[TBL] [Abstract][Full Text] [Related]
39. [Effect of combined therapy with selective beta 1- and alpha 1-adrenergic agonists upon postprandial hypotension in patients with progressive autonomic failure].
Hirayama M; Koike Y; Watanabe H; Kaneoke Y; Takahashi A
Rinsho Shinkeigaku; 1992 Nov; 32(11):1208-12. PubMed ID: 1284487
[TBL] [Abstract][Full Text] [Related]
40. Lack of renal effects of fish oil administration in patients with advanced cirrhosis and impaired glomerular filtration.
Badalamenti S; Salerno F; Salmeron JM; Lorenzano E; Rimola A; Ginés P; Jimenez W; Graziani G; Arroyo V; Rodes J; Ponticelli C
Hepatology; 1997 Feb; 25(2):313-6. PubMed ID: 9021940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]